OncoInfluencers to Follow on Social Media: Dr. Melvin L.K. Chua
We are pleased to feature Dr. Melvin L.K. Chua, a leading clinician-scientist in oncology and radiation therapy, as our next OncoInfluencer.
About Melvin L.K. Chua
Dr. Melvin L.K. Chua is a Clinician-Scientist at the NCCS and Duke-NUS Medical School, and Principal Investigator of the Precision Radiotherapeutics and Oncology Programme, Division of Medical Sciences, supported by the NMRC Clinician-Scientist Award. He is also the Head of Department and Senior Consultant for Head and Neck and Thoracic Cancers, Division of Radiation Oncology, and Director of the Data and Computational Science Core at the NCCS. His research is focused on phase 2-3 trials in nasopharynx (NPC) and prostate cancers (PCa).
He is also on the scientific advisory board for the NPC Guangzhou-Singapore Trial Network, a board member on the Head Neck Cancer International Group (HNCIG), and the Clinical Trials Scientific Committee Chair of HNCIG. Dr. Chuaam’s other academic activities include his present role as the Editor-in-Chief, Annals of Nasopharynx Cancer and his previous role as the Associate Senior Editor for the Head and Neck Cancer Section of the International Journal of Radiation Oncology Biology Physics – Official journal of the American Society of Radiation Oncology.
Dr. Melvin L.K. Chua actively shares updates from his cutting-edge research in precision radiotherapeutics and oncology on X/Twitter and LinkedIn. His posts cover critical topics such as phase 2-3 clinical trials in nasopharyngeal (NPC) and prostate cancers (PCa), advancements in radiation oncology, and the integration of data and computational science in cancer treatment. Dr. Chua also discusses the importance of precision medicine in improving patient outcomes, as well as his involvement in global cancer initiatives, including his leadership roles in the Head Neck Cancer International Group (HNCIG) and the NPC Guangzhou-Singapore Trial Network.
Follow Dr. Melvin L.K. Chua on LinkedIn and X/Twitter to stay updated on his cutting-edge research and clinical contributions in the fields of head and neck cancer, prostate cancer, and radiation oncology.
While staying tuned for upcoming Oncoinfluencers, check out previous profiles on our website on influential voices in the oncology community.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023